Standard BioTools Inc. (LAB) stock
Close on Nov 11, 2026Market cap $252.43MP/E 2.9Yield –
Standard BioTools Inc. saw revenue fall 4.8% to $84.60M over the twelve months to Jun 30, 2026. Free cash flow was -$82.58M. At the latest close the market valued the company at $252.43M, 2.9 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $252.43M
- P/E ratio
- 2.9
- Price to sales
- 2.98
- Price to book
- 0.47
- Dividend yield
- –
- Free cash flow yield
- -32.71%
Fundamentals
- Revenue
- $84.60M
- Net income
- $84.91M
- EPS, diluted
- $0.22
- Free cash flow
- -$82.58M
- Book value per share
- $1.38
- Diluted shares
- 391M
Trading
- Next earnings
- Q3 FY2026, expected soon
- Previous close
- $0.67
- Open
- $0.68
- Day's range
- $0.64 – $0.72
- Volume
- 406,134
- Average volume (20 days)
- 796,724
- Beta (5 years)
- 1.53
- 52-week range
- $0.59 – $1.72
- RSI (14 days)
- 48.5
- Volatility (1 year)
- 68.1%
- Relative volume
- 0.29×
- WACC
- 12.5%
Market cap history
Month-end market cap since 2011, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.
| Period | LAB | S&P 500 | Difference | LAB per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -6.7% | -2.4% | −4.3 pts | ||
| 3 months | -18.3% | -1.2% | −17.2 pts | ||
| Year to date | -49.8% | +12.3% | −62.1 pts | ||
| 1 year | -46.0% | +12.4% | −58.4 pts | ||
| 3 years | -70.5% | +78.8% | −149.3 pts | -33.4% | +21.4% |
| 5 years | -86.3% | +75.2% | −161.5 pts | -32.8% | +11.9% |
| 10 years | -89.9% | +311.1% | −401.0 pts | -20.5% | +15.2% |
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Standard BioTools filed with the SEC as exhibits to Form 8-K or 6-K
- Update
- Update
- Update
- Results
- Update
- Update
About Standard BioTools
Pharmaceutical Preparations
Standard BioTools Inc. provides life science tools and technologies designed to assist biomedical researchers in developing therapeutics. The company offers a portfolio of instrumentation, consumables, and laboratory services supporting multi-omic research across proteomics and genomics. Its core commercial platforms include CyTOF for single-cell mass cytometry, Hyperion for spatial biology and imaging mass cytometry, and Biomark for genomic analyses. These products enable scientists to analyze cellular functions, map tissue architectures, and explore disease mechanisms in areas such as oncology, immunology, and neurology.
Company profile, executives and historyStandard BioTools stock: common questions
What is Standard BioTools's stock price?
LAB closed at $0.64 on Nov 11, 2026, down 3.31% on the day. Over the past 52 weeks it traded between $0.59 and $1.72.
What is Standard BioTools's market cap?
Standard BioTools was worth $252.43M at the close on Nov 11, 2026: the share price times the diluted shares outstanding.
What is LAB's P/E ratio?
LAB trades at 2.9 times earnings, based on diluted earnings per share of $0.22 over the twelve months to Jun 30, 2026.
How much revenue does Standard BioTools make?
Standard BioTools reported revenue of $84.60M for the twelve months to Jun 30, 2026, down 4.8% from a year earlier.
Does Standard BioTools pay a dividend?
No. Standard BioTools has not paid a cash dividend over the last twelve months.
When does Standard BioTools report earnings next?
Standard BioTools's Q3 FY2026 results are due soon; the company has not yet filed them with the SEC.
How has LAB stock performed over the past year?
Including dividends, LAB returned -46.0% over the past year, against +12.4% for the S&P 500.
How many LAB shares are sold short?
2M shares were sold short at the latest FINRA report, 1.86% of the float, or 3.1 days of average trading volume.
Who are Standard BioTools's competitors?
Companies most similar to Standard BioTools by business, industry and size include BCYC, TNGX, WVE, KPTI, XLO.
See a number that looks wrong?